Scarica l'app Stockscreener
324.68
1.46%
4.68
Pre-mercato:
324.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$320.00
Aprire:
$318.82
Volume 24 ore:
907.86K
Relative Volume:
0.83
Capitalizzazione di mercato:
$31.87B
Reddito:
$3.17B
Utile/perdita netta:
$642.63M
Rapporto P/E:
30.16
EPS:
10.765
Flusso di cassa netto:
$516.49M
1 W Prestazione:
+6.77%
1M Prestazione:
+13.30%
6M Prestazione:
-3.46%
1 anno Prestazione:
-0.17%
Intervallo 1D:
$316.24
$325.11
Intervallo di 1 settimana:
$299.56
$325.11
Portata 52W:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Nome
Waters Corp
Settore
Industria
Telefono
(508) 478-2000
Indirizzo
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
324.68 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
TMO
Thermo Fisher Scientific Inc
|
514.23 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
195.87 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
574.00 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
117.50 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2026-02-10 | Ripresa | Barclays | Overweight |
| 2026-02-10 | Ripresa | Citigroup | Buy |
| 2026-02-10 | Ripresa | Evercore ISI | In-line |
| 2026-01-06 | Iniziato | Guggenheim | Buy |
| 2026-01-05 | Iniziato | William Blair | Outperform |
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2023-11-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-05-18 | Iniziato | Barclays | Overweight |
| 2022-05-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Aggiornamento | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Downgrade | Needham | Hold → Underperform |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Sell |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-09 | Downgrade | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-01-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Iniziato | Needham | Hold |
| 2018-12-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Downgrade | Goldman | Neutral → Sell |
| 2018-10-11 | Aggiornamento | Cleveland Research | Sell → Neutral |
Mostra tutto
Waters Corp Borsa (WAT) Ultime notizie
Waters Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Big Picture: Will Waters Corporation outperform small cap indexes2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn
IAWAI growth assumptions questioned as waters company prepares strategy - Waikato Times
WAT SEC FilingsWaters 10-K, 10-Q, 8-K Forms - Stock Titan
WAT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Waters prices $3.5B senior notes offering - MSN
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results - ADVFN
Waters Corporation (NYSE: WAT) Reports First Quarter 2021 Financial Results - ADVFN
Waters Corp Achieves Highest Daily Trading Volume of $270 Million, Rising 0.74% as Earnings Outlook Adjusts - Bitget
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Australia
WAT Earnings History & Surprises | EPS & Revenue Results | WATERS CORP (NYSE:WAT) - ChartMill
Waters (NYSE: WAT) highlights BD acquisition, 7% 2025 growth and performance-linked executive pay - Stock Titan
HARTFORD HEALTHCARE HLS FUND's Waters Corp(WAT) Holding History - GuruFocus
WAT Stock Price, Quote & Chart | WATERS CORP (NYSE:WAT) - ChartMill
Waters (WAT) Gains FDA Clearance for At-Home Cervical Cancer Scr - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp Stock Surges on FDA Clearance: What Investors Need to Know Now - AD HOC NEWS
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit - Benzinga
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay - Finviz
US FDA approves Waters' at‑home cervical cancer screening kit - Reuters
Waters (WAT) Gains FDA Approval for At-Home Cervical Cancer Scre - GuruFocus
FDA clears at-home HPV kit as 60% of cervical cancer cases hit unscreened people - Stock Titan
Waters Corp stock: What investors need to know in today's market - AD HOC NEWS
[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan
Waters Corporation (NYSE:WAT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Evercore ISI upgrades Waters stock rating on achievable targets By Investing.com - Investing.com Australia
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
Waters Corp : Evercore ISI Raises to Outperfo - Moomoo
Manufacturing Excellence Awards 2026: Waters Corp. - Worcester Business Journal
WAT Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Waters Corp (WAT) director gets deferred stock units grant - Stock Titan
Director Heather Knight granted deferred Waters (NYSE: WAT) stock units - Stock Titan
Waters Corp (MIL:1WAT) Bonds - GuruFocus
Parkman Healthcare Partners LLC's Waters Corp(WAT) Holding History - GuruFocus
Goldman Sachs Reinstates Buy Rating on Waters (WAT) Stock - GuruFocus
Waters Corp. stock rises Tuesday, still underperforms market - MarketWatch
Waters Corp (WAT) Expands After BD Diagnostic Solutions Acquisition - Insider Monkey
Waters Corp (WAT) Trading Down 3.79% on Mar 30 - GuruFocus
Waters Corp (LTS:0LTI) Bonds - GuruFocus
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; Waters Corp shows 0% stake (WAT) - Stock Titan
Waters (MIC:WAT-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - GuruFocus
Waters Corp Stock: Analytical Instruments Leader Faces Growth Challenges Amid Sector Tailwinds - AD HOC NEWS
Waters Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Waters (MIL:1WAT) NonCurrent Deferred Revenue : €0 Mil (As of Dec. 2025) - GuruFocus
Waters Corporation stock faces uncertainty amid Trump national security alert and market volatility - AD HOC NEWS
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT)'s Winning Formula: Financial Metrics and Compe - GuruFocus
Waters (WAT) Prices $3.5 Billion Senior Notes Offering - Insider Monkey
Waters Corp Azioni (WAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):